FENNEC PHARMACEUTICALS INC. (FENC) insider trading

By person

9 insiders · 25 transactions

1.2×

Jeffrey Hackman holds only 1.2 times base salary in stock. $728.98K of shares against $586.34K in salary for 2025.

Salary from the company's own proxy. The shares are what Jeffrey Hackman last reported holding, valued at $10.29, the price Common Shares was last bought or sold at on the open market here, on 15 Sep 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Southpoint Capital Advisors LP entity

10% owner

—

$9.71M (4)

−$9.71M

2,744,741

7.83%

$28.24M

−32.7%

Robert Andrade

Chief Financial Officer

—

$883.50K (1) scheduled

−$883.50K

248,558

0.7088%

$2.56M

+122.8%

Rosty Raykov

Former Director

—

$867.75K (10) scheduled

−$867.75K

124,411

0.3548%

$1.28M

+103.2%

Marco Maria Brughera

Director

—

$159.96K (1) scheduled

−$159.96K

0.0000%

$0.00

—

Pierre Sargis Sayad

Chief Medical Officer

—

$146.16K (1)

−$146.16K

13,701

0.0391%

$140.98K

—

Chris A Rallis

Director

—

$58.76K (1) scheduled

−$58.76K

63,077

0.1799%

$649.06K

+29.7%

Jeffrey S. Hackman

Chief Executive Officer

—

70,844

0.2020%

$728.98K

—

Christiana Marie Cioffi

Chief Strategy Officer

—

28,902

0.0824%

$297.40K

—

Terry L Evans

Chief Commercial Officer

—

24,181

0.0690%

$248.82K

—

FENNEC PHARMACEUTICALS INC.

What the insiders did Net selling

By person